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Abstract
Background: Headache disorders are common worldwide, causing pain and disability. India appears to have a very
high prevalence of migraine, and of other headache disorders in line with global averages. Our objective was to
estimate the burdens attributable to these disorders in order to inform health policy.
Methods: In a door-to-door survey, biologically unrelated adults (18–65 years) were randomly sampled from urban
and rural areas of Bangalore and interviewed by trained researchers. The validated structured questionnaire enquired
into several aspects of burden.
Results: Of 2,329 participants (non-participation rate 7.4 %), 1,488 (63.9 %; 621 male, 867 female) reported headache in
the preceding year. Symptom burden was high. Migraine (1-year prevalence 25.2 %) occurred on average on 28 days/
year but, in 38.0 % of cases (ie, 9.6 % of adults), on ≥3 days/month (≥10 % of days). All causes of headache on ≥15 days/
month (prevalence 3.0 %) occurred on a mean of 245 days/year. Both these and migraine were rated severe in intensity.
Participants with headache lost 4.3 % of productive time; those with migraine lost 5.8 % (equating to 1.5 % from the adult
population). Lost paid worktime accounted for 40 % of this, probably detracting directly from GDP.
We estimated population-level disability attributable to migraine using the disability weight from GBD2010 for the ictal
state (0.433). Mean disability per person with migraine was 1.8 %, reducing the functional capacity of the entire adult
population by 0.46 %.
Fewer than one quarter of participants with headache had engaged with health-care services for headache in the last
year. Actual expenditure on headache care was greatest among those with headache on ≥15 days/month (especially
probable medication-overuse headache), but otherwise not high. Expressed willingness to pay for effective treatment for
headache was higher, signalling dissatisfaction with current treatments.
Conclusions: In Karnataka State, southern India, prevalent headache disorders, especially migraine, give rise to
commensurately heavy burdens. Limited access to health care fails to alleviate these. Structured headache services, with
their basis in primary care, are the most efficient, effective, affordable and equitable solution. They could be implemented
within the health-care infrastructure of India and are likely to be cost-saving. This solution requires political will, itself
dependent on awareness.
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Background
Primary headache disorders are not only among the com-
monest disorders in the world but also among the most
burdensome [1, 2], causing pain, substantial disability, lost
productive time and, consequentially, very large financial
losses [3]. The Global Burden of Disease Study 2010
(GBD2010) reported tension-type headache (TTH) as the
second most prevalent disorder worldwide and migraine
as the third [1], but migraine far outweighs TTH as a
cause of disability. GBD2010 ranked migraine as the sev-
enth highest specific cause of disability in the world [1, 2],
but this was an underestimate: data gathered since, and
included in the subsequent Global Burden of Disease
Study 2013 (GBD2013), elevated it to sixth [4].
Medication-overuse headache (MOH), perhaps best
regarded as a complication either of migraine or of TTH,
since its occurrence is almost always as a consequence of
mismanagement of one or the other, has also entered the
top 20 causes of disability in GBD2013 [4].
In the context of India, these facts and statistics take on
some significance. First, India has more than 1.2 billion
people [5], over 16 % of the world’s population. Second,
while headache disorders generally appear to be no less
common in this country – at least in Karnataka State –
than elsewhere in the world [6], the prevalence of
migraine is notably higher than the average reported from
other countries [1, 7]. In our first report of this study, the
1-year prevalence of migraine was 25.2 % and of TTH
35.1 %; the prevalence of all headache on ≥15 days/month
was 3.0 % [6]. In GBD2010, the estimated worldwide
prevalence of migraine was 14.7 % and of TTH 20.8 %
[1]. The review of surveys by Stovner et al. estimated
the mean global prevalence of all causes of headache
on ≥15 days/month at 3.0 % [7]. It is likely, therefore,
that very high burdens are attributable to headache in
India; but, if so, they are largely disregarded by health
services because knowledge of them is not available to
inform health policy.
Across the world, knowledge for public-health policy is
being gathered by a series of population-based studies
supported by Lifting The Burden (LTB) [8, 9], a UK-
registered non-governmental organisation conducting the
Global Campaign against Headache [10] in official
relations with the World Health Organization [11]. Meth-
odology has been developed for this purpose [12, 13],
focusing on the headache disorders of public-health
importance: migraine, TTH, MOH and other causes of
headache occurring on ≥15 days/month. One study per-
formed as part of this series was conducted in Karnataka
State in southern India. The prevalence data from this
study (referred to above) have been published already [6];
our purpose here, again to inform health policy, is to add
estimates of burden attributable to these headache disor-
ders, based on enquiries conducted during the survey.
Methods
The methodology of the study has been published in
detail previously [14] and is described only briefly here.
The institutional ethics committee of the National
Institute for Mental Health and Neuro-Science (NIM-
HANS) approved the study protocol. Informed consent
was obtained from all participants.
It was a cross-sectional survey, conducted during
May to November 2009. It sampled urban and rural
areas in and around Bangalore: Kempegowdanagara, an
urban administrative ward in the city of Bangalore, and
Uyamballi and Doddaaladahalli, two large villages lo-
cated 75–80 Km from Bangalore. Trained interviewers
travelled to these communities, selected households
through multistage cluster sampling, called at each chosen
household, listed all adult members (aged 18–65 years),
randomly selected one and interviewed that person using
a structured questionnaire. This instrument was an adap-
tation of the HARDSHIP questionnaire [13], translated
into the local language (Kannada) in accordance with
LTB’s translation protocol for hybrid documents [15] and
validated [14]. The headache screening question (“Have
you had headache during the last year?”) and diagnostic
questions based on ICHD-II [16] were followed, for those
reporting headache, by multiple question sets enquiring
into various aspects of burden: symptom burden, lost pro-
ductive time, health-care utilisation, personal expenditure
on health care and willingness to pay for effective care.
Any participant reporting more than one headache type
was asked to focus only on the one that was subjectively
the most bothersome for purposes of diagnosis and bur-
den attribution.
Diagnoses were not made by the interviewers but later,
by algorithm applied to the responses to the diagnostic
questions. Participants with headache on ≥15 days/month
were first identified; among these, any with medication
overuse were diagnosed as probable MOH (pMOH), the
remainder as “other headache on ≥15 days/month”. The
algorithm then applied ICHD-II criteria to all other cases
in hierarchical sequence: first for migraine, then for TTH,
then for probable migraine and finally for probable TTH.
Cases remaining were considered unclassifiable. In the
later analysis, migraine and probable migraine were
grouped as all-migraine, and TTH and probable TTH as
all-TTH.
Statistics and analyses
Data were entered into a secure database and statistical
analyses were performed using EPI INFO [17] and SPSS
15 [18].
We used proportions, 95 % confidence intervals (CIs),
means and standard deviations (SDs), medians and quar-
tiles to summarise the distributions of variables, and chi-
squared, Student’s t-test or ANOVA to test for significance
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of differences. We used Pearson’s coefficient to test for
correlation between continuous variables. We set the level
of significance at 5 %.
Headache frequency was reported as headache days/
year. Usual intensity was reported by participants on a
3-point categorical score as “not bad”, “quite bad” and
“very bad”, which we equated to “mild”, “moderate” and
“severe”; these were converted to a numerical rating
scale 1–3 and treated as continuous data to derive
means (±SD) and medians. We assessed lost productive
time as a consequence of headache using the HALT
questionnaire [19], enquiring separately into lost paid
worktime (days lost from paid employment: questions 1
and 2) and lost household worktime (days lost from
home chores: questions 3 and 4). The enquiry period
was the preceding 3 months. To estimate the proportion
of all productive time lost to each headache type, we
assumed there were 240 working days/year. We then
calculated the total working days/year available to all
participants with each headache type (denominator) as
n*240, and used the total reported days lost by them as
numerator.
We estimated population-level disability from migraine
using the disability weight (DW) from GBD2010 for the
ictal state of migraine (0.433) [20]. We calculated mean
time spent in the ictal state as a product of mean attack
frequency and mean attack duration, and derived from
this the proportion of total time that was spent in the ictal
state. We multiplied this proportion by the DW to calcu-
late individual disability, and the product by the preva-
lence of migraine to arrive at population-level disability.
Results
There were 2,329 participants (1,141 [49.0 %] male,
1,188 [51.0 %] female; mean age 38.0 [±12.7] years; 1,103
[47.4 %] from rural areas, 1,226 [52.6 %] urban). The
overall participation rate was 92.6 % (eligible population
n = 2,514). The distributions of gender, age and habita-
tion in the participating sample, described in detail pre-
viously, were comparable to those of the population of
Karnataka [14].
Headache in the preceding year was reported by 1,488
participants (63.9 %; 621 male, 867 female), along with
attributable symptom burden in terms of frequency and
intensity. As reported previously, the age-standardised 1-
year prevalence of migraine was 25.2 % and of TTH was
35.1 %; the age-standardised prevalence of all causes of
headache on ≥15 days/month was 3.0 % and of pMOH
was 1.2 % [6]. Frequency for each of the headache types
is presented in Table 1. The majority of participants with
migraine had relatively infrequent attacks, but a sizeable
minority (227/597; 38.0 %) had ≥3 attacks/month. Over-
all, migraine was more frequent than TTH, with a
median of 2 days/month affected. Migraine was in
almost all cases a moderate-to-severe headache, TTH
mostly mild-to-moderate; headache on ≥15 days/month,
including pMOH, was rated severe by two thirds of
those affected (Table 1).
Lost productive time is shown in Table 2. It should be
noted that many median values were zero (ie, at least
half of people in the category of interest lost no product-
ive time). For the episodic headaches this was so in most
categories: for TTH all, and for migraine nearly all.
Losses that were spread inconspicuously between paid
and household worktime became apparent in total lost
productive time. The SDs confirm that distributions
were skewed, the usual pattern incorporating a severely
affected minority.
Among participants with migraine, rural dwellers and
females lost more time on average than urban dwellers
and males, in both cases mostly accounted for by lost
household worktime. Similar differences occurred among
those with TTH. Much greater losses per person were at-
tributable to the various causes of headache on ≥15 days/
month, including pMOH, although again several medians
were zero.
Regardless of headache type, lost productivity corre-
lated with headache frequency, both expressed in days/
year, albeit only weakly (Pearson correlations: lost paid
worktime 0.271; lost household worktime 0.360; total
lost productivity 0.402; all p < 0.0005).
The estimates of all productive time lost to each
headache type are in Table 3. All headache cost 4.3 %
of all productive time, females losing more than males
(p = 0.0155). Migraine caused almost threefold higher
losses than TTH (again females more than males,
although not significantly [p = 0.1021]), but those due
to headache on ≥15 days/month, and especially pMOH,
were far higher still.
In expected relation to lost productive time, we made
an estimate of the population-level disability from
migraine. Participants with migraine reported attacks on
28 days/year on average (Table 1), with a mean duration
of 13.1 (±16.9) hours per attack; average time spent in
the ictal state as a proportion of all time available to that
person was therefore 4.2 % ([13.1/24]*[28/365]*100).
Multiplying this by the DW for the ictal state of
migraine (0.433) [20], we calculated that each person
with migraine carried an average 1.8 % disability burden.
Since the prevalence of migraine in the sample was
25.6 % (597/2,329), this disability spread among the
whole adult population was 0.46 %. In other words,
migraine reduced the functional capacity of the entire
adult population by 0.46 %.
We asked about consultations with health-care profes-
sionals specifically for headache in the last year. About
one quarter of participants responded positively, the
proportion depending on headache type. Of those with
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Table 1 Symptom burden: headache frequency and intensity by headache type
Migraine (n = 597) Tension-type headache (n = 811) pMOH (n = 28) Other headache on ≥15 d/m (n = 40)
Headache frequency (headache days/year)
mean ± SD 28 ± 27 17 ± 20 226 ± 59 259 ± 78
median 24 10 216 240
Headache intensity n (%)
“not bad” (=1) 20 (3.4) 235 (29.0) 2 (7.1) 4 (10.0)
“quite bad” (=2) 346 (58.0) 505 (62.3) 7 (25.0) 9 (22.5)
“very bad” (=3) 231 (38.7) 71 (8.8) 19 (67.9) 27 (67.5)
mean ± SD 2.4 ± 0.5 1.8 ± 0.6 2.6 ± 0.7 2.6 ± 0.6
median 2.0 2.0 3.0 3.0
n number of participants with the headache type, pMOH probable medication-overuse headache, d/m days/month
Table 2 Lost productive time attributed to headache for each headache type, by gender and by urban and rural habitation
Lost productive time (days per person per 3 months)
Total lost productive time Lost paid worktime Lost household worktime
Mean ± SD Median Mean ± SD Median Mean ± SD Median
Migraine
male (n = 212) 2.6 ± 5.6 1 1.3 ± 4.8 0 1.3 ± 2.9 0
female (n = 385) 4.0 ± 6.1** 2 1.5 ± 3.6 0 2.5 ± 4.5*** 0
rural (n = 328) 4.4 ± 6.6 3 1.6 ± 3.8 0 2.8 ± 4.9 1
urban (n = 269) 2.3 ± 4.8*** 0 1.1 ± 4.4 0 1.2 ± 2.4*** 0
Total (n = 597) 3.5 ± 6.0 2 1.4 ± 4.1 0 2.1 ± 4.0 0
Tension-type headache
male (n = 388) 1.0 ± 3.1 0 0.4 ± 1.8 0 0.6 ± 1.9 0
female (n = 423) 1.4 ± 4.3 0 0.4 ± 2.1 0 1.0 ± 2.6* 0
rural (n = 416) 1.5 ± 4.8 0 0.6 ± 2.5 0 1.0 ± 2.8 0
urban (n = 395) 0.8 ± 2.1** 0 0.2 ± 1.0** 0 0.6 ± 1.6* 0
Total (n = 811) 1.2 ± 3.8 0 0.4 ± 1.9 0 0.8 ± 2.3 0
Probable medication-overuse headache
male (n = 4) 18.3 ± 21.3 9 14.5 ± 24.0 4 3.8 ± 4.8 2.5
female (n = 24) 13.1 ± 17.7 7.5 2.4 ± 8.1 0 10.7 ± 11.5 7
rural (n = 17) 14.1 ± 22.0 5 6.5 ± 14.7 0 7.6 ± 11.4 5
urban (n = 11) 13.5 ± 9.7 10 0.5 ± 1.5 0 13.0 ± 10.0 10
Total (n = 28) 13.9 ± 17.9 8 4.1 ± 11.8 0 9.7 ± 11.0 6
Other headache on ≥15 days/month
male (n = 14) 7.3 ± 9.4 2 6.4 ± 9.5 1 0.9 ± 3.5 0
female (n = 26) 10.9 ± 9.9 10 4.8 ± 8.4 0 6.0 ± 6.4** 5
rural (n = 19) 12.1 ± 11.6 12 6.9 ± 10.0 0 5.1 ± 6.7 3
urban (n = 21) 7.4 ± 7.3 5 4.0 ± 7.2 0 3.5 ± 5.4 0
Total (n = 40) 9.6 ± 9.7 8 5.4 ± 8.7 0 4.3 ± 6.0 0
n number of participants in the category
*** p < 0.001; ** p < 0.01; * p < 0.05
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migraine, 30.3 % had consulted, 84.0 % of these in pri-
mary care (Table 4). The proportion was lowest among
participants with TTH and far greater among those with
headache on ≥15 days/month.
Table 5 shows participants’ estimates of their actual
expenditure during the last 3 months on health care for
headache, including consultations (if any) and medication.
The pattern was similar: by far the greatest expenditures
were claimed by those with headache on ≥15 days/month,
and, among these, by participants with pMOH. Females
spent more than males for all specific headache types, and
rural expenditure was greater than urban except for
pMOH, although, with very wide variations, none of these
differences was significant. The table also shows estimated
expenditure as a percentage of total quarterly household
income, since income must usually constrain what is
spent. To make this calculation we multiplied reported
monthly income by three. This analysis greatly highlights
the expenditure by those with pMOH.
Finally, we asked participants how much they would
be willing to pay for effective treatment for their head-
ache (meaning that it would no longer bother them), if it
were available. This enquiry was intended as an overall
measure of burden [12, 13]. Table 6 indicates a grad-
ation: pMOH > other headache on ≥15 days/month >
migraine > TTH. It is noticeable (see bottom row) that
considerably more would be paid for effective treatments
for migraine or TTH than, reportedly, actually had been
paid for current treatments.
Discussion
Our earlier report of this study showed that headache
disorders were common in Karnataka State [6]. We ob-
served that these data represented, for the time being,
the best information available for the entire country and
its more than 1.2 billion people [5]. The age-standardised
1-year prevalence of migraine, at 25.2 %, was well above
the global average of 14.7 % [1]. The estimated prevalence
of all headache occurring on ≥15 days/month was 3.0 %,
equal to the global mean [7, 21], while that of pMOH was
1.2 %, within the range of most national estimates of 1–
1.5 % [22].
The importance of these findings may seem self-
evident for this very large population, but becomes
much highlighted when burden data are added to them.
Migraine, so highly prevalent, and the other headache
disorders no less common than elsewhere in the world,
generate commensurately heavy burdens. Among these
are symptom burden – giving rise to health-care
demand, disability, personal financial burden, and huge
consequential losses in productive time – a large part of
which translate into losses from gross domestic product
(GDP). We discuss these, although not in this order.
Before doing so, we note the principal limitation inher-
ent in this type of study. Our data were gathered in a
cross-sectional survey, by questionnaire, from what we
believe were a representative sample, but dependent on
recall – in many cases over the preceding 3 months. The
error associated with inexact recall has not been estab-
lished [12], but there is no reason to suppose that it
results in over- rather than underestimation.
Symptom burden
On all measures, migraine was a more burdensome
headache than TTH, while the various causes of head-
ache on ≥15 days/month, especially pMOH, were associ-
ated with greatest individual burden. In terms of
symptoms, obviously the last occurred most frequently
(on 245 days/year on average), but they were also, along
with migraine, rated severe in intensity. They represent a
Table 3 Estimated proportion (%) of all productive time lost to all headache and each headache type
Estimated proportion
All headache Migraine Tension-type headache pMOH Other headache on ≥15 d/m
n % n % n % n % n %
Total 1,488 4.3> 597 5.8 811 2.0 28 23.2 40 16.0
male 621 3.0 212 4.3 388 1.7 4 30.5 14 12.2
female 867 5.2 385 6.7 423 2.3 24 21.8 26 18.2
n number of participants in the category, pMOH probable medication-overuse headache, d/m days/month
Table 4 Consultation with a health-care professional in the last year by headache type
Migraine (n = 597) Tension-type headache (n = 811) pMOH (n = 28) Other headache on ≥15 d/m (n = 40)
Any consultation made (% of n) 30.3 16.6 78.6 72.5
Primary care doctor (%) 84.0 81.6 72.7 51.7
Specialist doctor (%) 13.2 13.6 27.3 41.4
Others (%) 2.8 4.8 0 6.8
n number of participants with the headache type, pMOH probable medication-overuse headache, d/m days/month
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very high symptom burden for 3 % of the adult popula-
tion. Migraine occurred on average more than twice a
month, which itself is not an unusual finding in the world
[7], but 38.0 % of those with this disorder in Karnataka –
that is 9.6 % of the adult population – were affected
on ≥3 days/month (at least 10 % of days). This has
important implications for health care, which we dis-
cuss later. Even if no account is taken of TTH, the
symptom burden of headache here is heavy.
Lost productive time
On most measures, females as a group reported greater
burden than males, which was largely attributable to
higher prevalence [6]. They also tended individually to
report greater burden. However, this differential was not
clearly seen in lost paid worktime, which almost
certainly reflected the local culture of relatively few
women being in paid employment. In estimating lost
proportions of all productive time, we assumed there
were 240 working days per year, which might not have
been a fair assumption for household work, but there
was no clear basis for any other assumption.
Lost productive time, perhaps especially including lost
paid worktime, is one of the major burdens of headache.
It has substantial implications not only for those directly
affected but also for their dependents and society [12, 13].
In this survey, while the heavy individual burdens attribut-
able to pMOH and other headache on ≥15 days/month
are obviously of considerable importance to those affected,
societal interest may focus on the 4.3 % of all productive
time lost to headache disorders collectively, given that this
was the average for the nearly two thirds (63.9 %) of the
population who reported headache. This meant the popu-
lation as a whole aged 18–65 years (effectively the working
population) lost 2.7 % (4.3*0.639) of its entire productive
time to headache – more than six days a year. This is an
enormous loss. Those with migraine (25.2 % of the popu-
lation) lost 5.8 % of their productive time; they were there-
fore responsible for a 1.5 % loss from the productive time
of the population as a whole – nearly 4 days a year. Lost
Table 5 Participants’ estimates of their actual expenditure during the last 3 months on health care for headache by headache type
Estimated expenditure (INR) Migraine (n = 597) Tension-type headache (n = 811) pMOH (n = 28) Other headache on ≥15 d/m (n = 40)
≤100 (%) 79.7 91.2 21.4 52.5
101–500 (%) 15.2 6.9 53.6 35.0
501–1,000 (%) 2.7 1.2 14.3 2.5
>1,000 (%) 2.3 0.6 10.7 10.0
Mean ± SD 112 ± 307 49 ± 218 532 ± 710 474 ± 1,083
male 71 ± 143 44 ± 232 289 ± 383 517 ± 1,558
female 134 ± 366 54 ± 204 573 ± 748 451 ± 751
urban 103 ± 300 34 ± 177 775 ± 922 330 ± 657
rural 119 ± 314 63 ± 250 375 ± 501 634 ± 1,417
Median 10 5 275 100
% of total household income
mean ± SD 6.7 ± 49.9 2.4 ± 14.9 32.9 ± 76.9 42.8 ± 172.4
median 0.4 0.1 7.4 1.8
INR Indian rupee, n number of participants with the headache type, pMOH probable medication-overuse headache, d/m days/month
Table 6 Participants’ estimates of their willingness to pay (WTP) for effective treatment for headache, as an overall measure of
burden, by headache type
Reported amount willing to pay (INR) Migraine
(n = 597)
Tension-type headache (n = 811) pMOH (n = 28) Other headache on ≥15 d/m (n = 40)
≤100 (%) 64.8 77.3 28.6 40.0
101–500 (%) 30.7 19.5 57.1 50.0
501–1,000 (%) 3.0 2.0 3.6 7.5
>1,000 (%) 1.5 1.2 10.7 2.5
Mean ± SD 206 ± 452 191 ± 914 435 ± 577 309 ± 376
Median 100 50 200 200
Mean ratio of WTP to actual expenditure 5.8 ± 18.1 8.8 ± 22.3 1.8 ± 3.0 2.4 ± 3.7
INR Indian rupee, n number of participants with the headache type, pMOH probable medication-overuse headache, d/m days/month
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paid worktime accounted for 40 % of this (Table 2), which
might directly detract from GDP.
Disability
It is of interest to compare this reported lost productiv-
ity from migraine (1.5 %) with the disability estimate for
the population attributable to those with migraine. This
was considerably lower (0.46 %). It is important to rec-
ognise that lost productive time as captured by the
HALT questionnaire [19] (and MIDAS, from which it
derives [23]) is not a measure of disability but of behav-
ioural response to impairment, correlating imprecisely
with disability measures while being an important meas-
ure in its own right [13]. On the other hand, 5.8 % (the
proportion of lost productive time) is only modestly
higher than 4.2 % (the average proportion of all available
time spent by those with migraine in the ictal state). It is
in the nature of migraine that motivation and energy are
lost, and that these symptoms, also expected to contrib-
ute to lost productivity, may for some time outlast what
is described as the ictal state. Important questions there-
fore arise about the relationship between disability and
productivity. In Zambia, with a somewhat lower
migraine prevalence of 22.9 % but higher attack fre-
quency (41 days/year) and considerably longer reported
mean duration (36 h), the same comparison found the
disability estimate (0.98 %) to be similarly smaller than
the reported total lost productivity (recalculated using
240 days as the denominator as 3.2 %) [24].
Health care contact and expenditure
We noted above that 38.0 % of those with migraine (9.6 %
of the adult population) were affected on ≥3 days/month.
This is often seen as a threshold for prophylactic medica-
tion, and therefore for requiring professional health care.
In fact, among participants with migraine, not very far
short of that proportion (30.3 %) had had contact with a
health-care professional (mostly in primary care) at least
once in the preceding year. Overall, slightly less than one
quarter of participants with headache had seen a health-
care professional in the preceding year. Unsurprisingly,
much higher proportions (about three quarters) of those
with headache on ≥15 days/month had done so, and were
much more likely to have progressed to specialist care –
yet still they had headache on ≥15 days/month, including
pMOH. We were not able to assess how effective the
encounters with health-care professionals had been, or the
benefits of any health care or advice offered, but it should
be recognised that the measured burdens existed despite
whatever health care was being provided.
Estimates (by participants) of actual expenditure on
health care show that more was spent on migraine than
on TTH, but the medians indicate that the majority of
those affected, in either case, spent very little indeed.
The much higher expenditure by those with pMOH pre-
sumably reflected costs of medications, although they
also consulted more.
Willingness to pay
WTP is considered to be an overall measure of burden
[12, 13], although it is difficult to ground it. Further-
more, in similar studies in Zambia [24] and Georgia
[25], WTP did not correlate with headache type or fre-
quency, or with lost productive time. Clearly its determi-
nants are complex. We are particularly cautious in
drawing conclusions related to income, which in the
social setting of India may be under-reported, especially
by those close to the poverty line, in expectation of
higher social security benefits.
What is possible is to make comparisons with partici-
pants’ reported actual expenditure. While the latter
might be inaccurate, participants would have had those
reports in mind when considering WTP. It is therefore
informative that the mean ratio of WTP to reported
actual expenditure for migraine was close to six and for
TTH close to nine. The difference between these prob-
ably reflected the much lesser amount expended on
TTH, while the low ratios for MOH (1.8) and other
headache on ≥15 days/month (2.4) were, even more
probably, similarly influenced by the potentially impov-
erishing expenditures on these disorders. The clear
implication of these comparisons is that a level of dissat-
isfaction existed with current treatments.
Evidence of unmet need
From all of these findings, the picture emerging in
Karnataka is of a high proportion of people in a very
large population with heavy symptom burdens attributable
to headache, leading to disability and very substantial lost
productivity. For whatever reasons, contact with health-
care professionals is achieved only by a minority. Apparent
dissatisfaction with treatments probably reflects this.
This is a picture of unmet health-care need, because
headache disorders are largely treatable [26]. Further-
more, because the lost-productivity (indirect) costs of
untreated headache are enormous [3] and treatments
can be highly cost-effective [27], there is an expectation
that expenditure on treatment would be cost-saving
overall [28].
Conclusions
In Karnataka State, in southern India, a very high preva-
lence of migraine and levels of TTH, pMOH and other
headache on ≥15 days/month similar to global averages
give rise to commensurately heavy burdens. Among
these are huge losses in productive time, a large part of
which translate into losses from GDP. Care must be
exercised in extrapolating beyond Karnataka, and we
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have discussed this issue previously [6]. But for the
moment, while this remains the only study of its type in
India, it is a fact that the data from it are the best avail-
able for all India.
A crucial finding is that the limited access to health
care, which the study has demonstrated, fails to alleviate
these burdens. Effective treatments exist [26], and could
be made available through structured headache services,
with their basis in primary care, which are the most effi-
cient, effective, affordable and equitable solution [28].
Their implementation would be with the expectation of
substantial cost-saving [27, 28]. The three-tier model
proposed by LTB for Europe [29] would readily adapt to
the health-care infrastructure of India. This solution
requires political will, which itself is dependent on
awareness.
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